Tech Company Financing Transactions
Juvena Therapeutics Funding Round
Bison Ventures, Eli Lilly and Company and Manta Ray Ventures invested in a $33.5 million Series B funding round for Juvena Therapeutics. The financing round closed on 1/13/2026.
Transaction Overview
Company Name
Announced On
1/13/2026
Transaction Type
Venture Equity
Amount
$33,500,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
640 Galveston Dr.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Our mission is to unlock the therapeutic potential of secreted proteins and to engineer them into life-saving therapeutics. Juvena Therapeutics is a venture-backed biotechnology company unlocking the therapeutic potential of stem cell-secreted proteins and accelerating their development into life-saving therapeutics for chronic and age-related diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hanadie Yousef
Chief Scientific Officer
Jeremy O'Connell
Vice President
Mohammad Tabrizi
Browse more venture capital transactions:
Prev: 1/12/2026: VieCure venture capital transaction
Next: 1/13/2026: Wasabi Technologies venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs